Imre Noth, MD, is an expert on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis. He has joined UVA as chief of the Division of Pulmonary and Critical Care Medicine.
Category: Pulmonology (Page 2)
Ex Vivo Lung Perfusion extends the period of time lungs can remain viable outside of the body, giving lung recipients access to lungs in locations beyond the region in which they are listed.
The UVA Interstitial Lung Disease Program is one of just 40 centers in the U.S. designated as a Pulmonary Fibrosis Foundation Care Network site, which speaks to the level of expertise and quality of care provided, as well as the progress being made at UVA in advancing treatment for these complex lung disorders.
The Severe Asthma Program continues to grow, with clinical services and research efforts specifically tailored to the needs of pediatric patients.